SlideShare a Scribd company logo
Gunawansa N,
Cassim MRN,
Wijeyaratne SM.
LIVE DONOR RENAL
TRANSPLANTATION
IN SRILANKA: FACTORS AFFECTING
OVERALL OUTCOME
Kidney transplantation is the most
effective therapy for ESRD
Ojo, J Am Soc Neph, 2001;12:589
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
1
Introduction
• Medium and long-term patient / graft survival
statistics after Live Donor Renal Transplantation (LDRT)
in Sri Lanka is largely unknown
• The overall outcome of LDRT depends on numerous
patient, donor and graft related variables
• Early identification of above predictors will help in
optimizing overall graft and patient outcomes
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
2
Methodology
• Prospective computerized database
• July 2006 – November 2011
• University Vascular and Transplant Unit, Colombo.
• Inclusion – All consecutive LDRT
• Exclusion – re-transplants, cadaveric
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
3
Methodology contd.
• All transplants performed as simultaneous donor and
recipient operations
• relatively constant cold ischaemia time of <2 hours
• Standardized immunosuppression regime (MMF,
prednisolone, cyclosporin/tacrolimus)
• Single dose monoclonal Ab induction for those with a HL
A mismatch >50%
Graft failure = need for maintenance dialysis,
re-transplantation or death due to graft non-function
within 1 yr of transplantation*
* Weiss-Salz et al. Clin Transplant 2004: 18: 571–575
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
4
Factors Determining Overall Outcome
• Type of donor (cadaveric vs. living)
• HLA Matching (related, unrelated)
• Sensitization
• Duration of pre-Tx dialysis
• Recipient Age
• Donor Age
• Cold ischaemia time, warm ischaemia time
• Acute rejection, chronic rejection
• Primary renal pathology
• CMV status
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
5
Variables analyzed
• Type of donor (cadaveric vs. living)
• HLA Matching and sensitization
• Duration of pre-Tx dialysis
• Recipient Age
• Donor Age
• Cold ischemia time
• Acute rejection, chronic rejection
• Primary renal pathology
• CMV status
• Multivariate log regression
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
6
Results
• 415 consecutive LDRT
• Complete follow-up data available – 397 (95%)
• Mean follow-up – 36 (3-66) months.
• Mean recipient age – 42 (17-72) years
• Mean donor age – 39 (20-60) years
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
7
18 Lost to follow up 397 (95%)
complete follow up data
32 (8%) Graft failures
365 (92%) Graft survival
24 PGF 8 SGF
337 (85%)
overall patient survival
5 re-transplanted
19 dead
5 re-transplanted or
3 on waiting list
415 LDRT
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
8
Results contd.
• Graft survival - 365/397 (92%)
• Graft Failures (GF); 32 (8%)
– 24 primary GF
– 05 successfully re-transplanted, 19 dead
– 08 secondary GF (Mean graft survival – 10 months)
– 05 re-transplanted, 03 activated on waiting list
• Overall patient survival – 337/397 (85%)
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
9
Causes of death
• Sepsis – 48 (80%)
• myocardial ischaemia – 4 (7%)
• stroke – 4 (7%)
• PE – 2 (3%)
• Unknown – 2 (3%)
Sepsis MI Stroke PE Other
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
10
Kaplan- Meir Curve – Graft survival
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
11
Predictors of GF
Variable Univariate analysis
P
Multivariate analysis
OR (95%CI) P
Recipient age: >50y/<50y 0.63 0.06-5.13 0.627
Donor age: >40y/<40y 0.85 0.12-4.22 0.71
CMV infection: Y/N 0.11 0.86-15.07 0.09
HLA mismatch: >50%/<50% 0.04 1.74-6.64 0.07
Pre-Tx dialysis:
<12 months/<12 months
0.03 1.17-13.54 0.06
Biopsy proven ac. Rejection:
Y/N
0.01 1.35-10.23 0.014
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
12
Conclusions
• Our mid-term graft / patient survival figures match
favorably with comparable settings elsewhere
• Pre-Tx dialysis for >1 year, HLA mismatch of >50%
showed a positive correlation to outcome although not
statistically significant
• Acute rejection within the first month was an independent
predictors of poor outcome
• Care of primary GF is suboptimal - restricted access to
HD, advanced immunosuppressant regimes and the
lack of a cadaveric transplant program until now
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
13
Recommendations
• Earlier referral for transplant
• Better HLA match wherever possible
• Increasing the donor pool (regular deceased donor
program)
• A better balance of saving the graft versus saving
the patient
LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME
14

More Related Content

What's hot

prognostic value of RIFLE criteria in acute renal failure in early post renal...
prognostic value of RIFLE criteria in acute renal failure in early post renal...prognostic value of RIFLE criteria in acute renal failure in early post renal...
prognostic value of RIFLE criteria in acute renal failure in early post renal...drahmedeltaher
 
Management of kidney transplant recipient (ayman refaie)
Management of kidney transplant  recipient (ayman refaie)Management of kidney transplant  recipient (ayman refaie)
Management of kidney transplant recipient (ayman refaie)
FarragBahbah
 
continous versus intermittent RRT in the ICU
continous versus intermittent RRT in the ICU continous versus intermittent RRT in the ICU
continous versus intermittent RRT in the ICU
Salwa Ibrahim
 
Journal club presentation 10 07 2015
Journal club presentation 10 07 2015Journal club presentation 10 07 2015
Journal club presentation 10 07 2015
Samuel Kariuki
 
Kidney transplantation candidate evaluation 2016 chaken maniyan
Kidney transplantation candidate evaluation 2016 chaken maniyanKidney transplantation candidate evaluation 2016 chaken maniyan
Kidney transplantation candidate evaluation 2016 chaken maniyan
CHAKEN MANIYAN
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
NephroTube - Dr.Gawad
 
The CHEST trial - HES in the ICU
The CHEST trial - HES in the ICUThe CHEST trial - HES in the ICU
The CHEST trial - HES in the ICUAndrew Ferguson
 
4 5764843123465258464
4 57648431234652584644 5764843123465258464
4 5764843123465258464
amarewoldie1
 
Kidney Donor evaluation
Kidney Donor evaluationKidney Donor evaluation
Kidney Donor evaluation
Dr. Prem Mohan Jha
 
immunosuppressive drugs
immunosuppressive drugsimmunosuppressive drugs
immunosuppressive drugs
drsalwa22000
 
Immunosupp
ImmunosuppImmunosupp
Immunosupp
drsalwa22000
 
Uremic Pruritis - Pathogenesis & Management - Dr. Gawad
Uremic Pruritis - Pathogenesis & Management - Dr. GawadUremic Pruritis - Pathogenesis & Management - Dr. Gawad
Uremic Pruritis - Pathogenesis & Management - Dr. Gawad
NephroTube - Dr.Gawad
 
Renal cell carcinoma after kidney transplantation 2017
Renal cell carcinoma after kidney transplantation 2017Renal cell carcinoma after kidney transplantation 2017
Renal cell carcinoma after kidney transplantation 2017
CHAKEN MANIYAN
 
2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...
2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...
2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...
Maarten Naesens
 
Introduction to Critical Appraisal 2015
Introduction to Critical Appraisal 2015Introduction to Critical Appraisal 2015
Introduction to Critical Appraisal 2015
Meguid Nahas
 
Evaluation of adult kidney transplant candidates
Evaluation of adult kidney transplant candidatesEvaluation of adult kidney transplant candidates
Evaluation of adult kidney transplant candidatesSunil Kumar Prajapati
 
CKD or C-K-D; Cardio-Kidney-Disease
CKD or C-K-D; Cardio-Kidney-DiseaseCKD or C-K-D; Cardio-Kidney-Disease
CKD or C-K-D; Cardio-Kidney-Disease
Meguid Nahas
 
Effects of deferasirox dose and decreasing serum ferritin
Effects of deferasirox dose and decreasing serum ferritinEffects of deferasirox dose and decreasing serum ferritin
Effects of deferasirox dose and decreasing serum ferritin
Malith Parakrama
 
Preparation for transplantation dr ahmed kamal
Preparation for transplantation dr ahmed kamalPreparation for transplantation dr ahmed kamal
Preparation for transplantation dr ahmed kamal
FarragBahbah
 
Myths in Nephrology 1
Myths in Nephrology 1Myths in Nephrology 1
Myths in Nephrology 1
Meguid Nahas
 

What's hot (20)

prognostic value of RIFLE criteria in acute renal failure in early post renal...
prognostic value of RIFLE criteria in acute renal failure in early post renal...prognostic value of RIFLE criteria in acute renal failure in early post renal...
prognostic value of RIFLE criteria in acute renal failure in early post renal...
 
Management of kidney transplant recipient (ayman refaie)
Management of kidney transplant  recipient (ayman refaie)Management of kidney transplant  recipient (ayman refaie)
Management of kidney transplant recipient (ayman refaie)
 
continous versus intermittent RRT in the ICU
continous versus intermittent RRT in the ICU continous versus intermittent RRT in the ICU
continous versus intermittent RRT in the ICU
 
Journal club presentation 10 07 2015
Journal club presentation 10 07 2015Journal club presentation 10 07 2015
Journal club presentation 10 07 2015
 
Kidney transplantation candidate evaluation 2016 chaken maniyan
Kidney transplantation candidate evaluation 2016 chaken maniyanKidney transplantation candidate evaluation 2016 chaken maniyan
Kidney transplantation candidate evaluation 2016 chaken maniyan
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
 
The CHEST trial - HES in the ICU
The CHEST trial - HES in the ICUThe CHEST trial - HES in the ICU
The CHEST trial - HES in the ICU
 
4 5764843123465258464
4 57648431234652584644 5764843123465258464
4 5764843123465258464
 
Kidney Donor evaluation
Kidney Donor evaluationKidney Donor evaluation
Kidney Donor evaluation
 
immunosuppressive drugs
immunosuppressive drugsimmunosuppressive drugs
immunosuppressive drugs
 
Immunosupp
ImmunosuppImmunosupp
Immunosupp
 
Uremic Pruritis - Pathogenesis & Management - Dr. Gawad
Uremic Pruritis - Pathogenesis & Management - Dr. GawadUremic Pruritis - Pathogenesis & Management - Dr. Gawad
Uremic Pruritis - Pathogenesis & Management - Dr. Gawad
 
Renal cell carcinoma after kidney transplantation 2017
Renal cell carcinoma after kidney transplantation 2017Renal cell carcinoma after kidney transplantation 2017
Renal cell carcinoma after kidney transplantation 2017
 
2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...
2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...
2014 06-05 Pretransplant Evaluation for Kidney Transplantation - Pretransplan...
 
Introduction to Critical Appraisal 2015
Introduction to Critical Appraisal 2015Introduction to Critical Appraisal 2015
Introduction to Critical Appraisal 2015
 
Evaluation of adult kidney transplant candidates
Evaluation of adult kidney transplant candidatesEvaluation of adult kidney transplant candidates
Evaluation of adult kidney transplant candidates
 
CKD or C-K-D; Cardio-Kidney-Disease
CKD or C-K-D; Cardio-Kidney-DiseaseCKD or C-K-D; Cardio-Kidney-Disease
CKD or C-K-D; Cardio-Kidney-Disease
 
Effects of deferasirox dose and decreasing serum ferritin
Effects of deferasirox dose and decreasing serum ferritinEffects of deferasirox dose and decreasing serum ferritin
Effects of deferasirox dose and decreasing serum ferritin
 
Preparation for transplantation dr ahmed kamal
Preparation for transplantation dr ahmed kamalPreparation for transplantation dr ahmed kamal
Preparation for transplantation dr ahmed kamal
 
Myths in Nephrology 1
Myths in Nephrology 1Myths in Nephrology 1
Myths in Nephrology 1
 

Similar to Live Donor Renal Transplantation in Sri Lanka

CRRT Principles (Thai).pdf
CRRT Principles (Thai).pdfCRRT Principles (Thai).pdf
CRRT Principles (Thai).pdf
justlim
 
Futility in liver transplantation
Futility in liver transplantation Futility in liver transplantation
Futility in liver transplantation
Abhishek Yadav
 
Preparation of tranplantation dr ahmed kamal
Preparation of tranplantation dr ahmed kamalPreparation of tranplantation dr ahmed kamal
Preparation of tranplantation dr ahmed kamal
FarragBahbah
 
Contraindications, futility & fraility in liver transplant
Contraindications, futility & fraility in liver transplantContraindications, futility & fraility in liver transplant
Contraindications, futility & fraility in liver transplant
Dr. Rohit Saini
 
HIV in Kidney Transplantation
HIV in Kidney TransplantationHIV in Kidney Transplantation
HIV in Kidney Transplantation
Wisit Cheungpasitporn
 
Hepatitis C virus & chronic kidney diseases
Hepatitis C virus & chronic kidney diseasesHepatitis C virus & chronic kidney diseases
Hepatitis C virus & chronic kidney diseasesSamir Haffar
 
Status Epilepticus
Status EpilepticusStatus Epilepticus
Status Epilepticus
NHS
 
Journal Club. Recurrence Of Nephrotic Syndrome Following Kidney Transplantat...
Journal Club. Recurrence Of Nephrotic Syndrome Following  Kidney Transplantat...Journal Club. Recurrence Of Nephrotic Syndrome Following  Kidney Transplantat...
Journal Club. Recurrence Of Nephrotic Syndrome Following Kidney Transplantat...
Ibrahim Sandokji
 
Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie
Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie
Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie
MNDU net
 
Systemic-Hypertension-and-Renal-transplantation-in-ARPKD.ppt
Systemic-Hypertension-and-Renal-transplantation-in-ARPKD.pptSystemic-Hypertension-and-Renal-transplantation-in-ARPKD.ppt
Systemic-Hypertension-and-Renal-transplantation-in-ARPKD.ppt
Huda693686
 
Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangit...
Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangit...Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangit...
Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangit...
Leonard Davis Institute of Health Economics
 
Preparation for transplantation (mih)
Preparation for transplantation (mih)Preparation for transplantation (mih)
Preparation for transplantation (mih)
FarragBahbah
 
Late Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome
Late Outcomes of Cord Blood Transplantation for Patients with Hurler SyndromeLate Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome
Late Outcomes of Cord Blood Transplantation for Patients with Hurler Syndromecordbloodsymposium
 
Update on Sepsis Management
Update on Sepsis ManagementUpdate on Sepsis Management
Update on Sepsis Management
Kristopher Maday
 
dr Franciscus Ginting - Sepsis PIN PAPDI Surabaya WS-051019.pdf
dr Franciscus Ginting - Sepsis PIN PAPDI  Surabaya WS-051019.pdfdr Franciscus Ginting - Sepsis PIN PAPDI  Surabaya WS-051019.pdf
dr Franciscus Ginting - Sepsis PIN PAPDI Surabaya WS-051019.pdf
corinafiqliyin
 
Update on Sepsis Management
Update on Sepsis Management Update on Sepsis Management
Update on Sepsis Management
Kristopher Maday
 
Liver disease in ICU – when to stop? by Julia Wendon
Liver disease in ICU – when to stop? by Julia WendonLiver disease in ICU – when to stop? by Julia Wendon
Liver disease in ICU – when to stop? by Julia Wendon
SMACC Conference
 
Truvada Randomized Trial of HBIG Withdrawal February 7 2014
Truvada Randomized Trial of HBIG Withdrawal February 7 2014Truvada Randomized Trial of HBIG Withdrawal February 7 2014
Truvada Randomized Trial of HBIG Withdrawal February 7 2014Dr. Lewis Teperman
 
Platelet Transfusion 2013
Platelet Transfusion 2013Platelet Transfusion 2013
Platelet Transfusion 2013derosaMSKCC
 
Isg chennai march 2015 rajasekar
Isg chennai march 2015 rajasekarIsg chennai march 2015 rajasekar
Isg chennai march 2015 rajasekar
rrsolution
 

Similar to Live Donor Renal Transplantation in Sri Lanka (20)

CRRT Principles (Thai).pdf
CRRT Principles (Thai).pdfCRRT Principles (Thai).pdf
CRRT Principles (Thai).pdf
 
Futility in liver transplantation
Futility in liver transplantation Futility in liver transplantation
Futility in liver transplantation
 
Preparation of tranplantation dr ahmed kamal
Preparation of tranplantation dr ahmed kamalPreparation of tranplantation dr ahmed kamal
Preparation of tranplantation dr ahmed kamal
 
Contraindications, futility & fraility in liver transplant
Contraindications, futility & fraility in liver transplantContraindications, futility & fraility in liver transplant
Contraindications, futility & fraility in liver transplant
 
HIV in Kidney Transplantation
HIV in Kidney TransplantationHIV in Kidney Transplantation
HIV in Kidney Transplantation
 
Hepatitis C virus & chronic kidney diseases
Hepatitis C virus & chronic kidney diseasesHepatitis C virus & chronic kidney diseases
Hepatitis C virus & chronic kidney diseases
 
Status Epilepticus
Status EpilepticusStatus Epilepticus
Status Epilepticus
 
Journal Club. Recurrence Of Nephrotic Syndrome Following Kidney Transplantat...
Journal Club. Recurrence Of Nephrotic Syndrome Following  Kidney Transplantat...Journal Club. Recurrence Of Nephrotic Syndrome Following  Kidney Transplantat...
Journal Club. Recurrence Of Nephrotic Syndrome Following Kidney Transplantat...
 
Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie
Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie
Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie
 
Systemic-Hypertension-and-Renal-transplantation-in-ARPKD.ppt
Systemic-Hypertension-and-Renal-transplantation-in-ARPKD.pptSystemic-Hypertension-and-Renal-transplantation-in-ARPKD.ppt
Systemic-Hypertension-and-Renal-transplantation-in-ARPKD.ppt
 
Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangit...
Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangit...Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangit...
Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangit...
 
Preparation for transplantation (mih)
Preparation for transplantation (mih)Preparation for transplantation (mih)
Preparation for transplantation (mih)
 
Late Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome
Late Outcomes of Cord Blood Transplantation for Patients with Hurler SyndromeLate Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome
Late Outcomes of Cord Blood Transplantation for Patients with Hurler Syndrome
 
Update on Sepsis Management
Update on Sepsis ManagementUpdate on Sepsis Management
Update on Sepsis Management
 
dr Franciscus Ginting - Sepsis PIN PAPDI Surabaya WS-051019.pdf
dr Franciscus Ginting - Sepsis PIN PAPDI  Surabaya WS-051019.pdfdr Franciscus Ginting - Sepsis PIN PAPDI  Surabaya WS-051019.pdf
dr Franciscus Ginting - Sepsis PIN PAPDI Surabaya WS-051019.pdf
 
Update on Sepsis Management
Update on Sepsis Management Update on Sepsis Management
Update on Sepsis Management
 
Liver disease in ICU – when to stop? by Julia Wendon
Liver disease in ICU – when to stop? by Julia WendonLiver disease in ICU – when to stop? by Julia Wendon
Liver disease in ICU – when to stop? by Julia Wendon
 
Truvada Randomized Trial of HBIG Withdrawal February 7 2014
Truvada Randomized Trial of HBIG Withdrawal February 7 2014Truvada Randomized Trial of HBIG Withdrawal February 7 2014
Truvada Randomized Trial of HBIG Withdrawal February 7 2014
 
Platelet Transfusion 2013
Platelet Transfusion 2013Platelet Transfusion 2013
Platelet Transfusion 2013
 
Isg chennai march 2015 rajasekar
Isg chennai march 2015 rajasekarIsg chennai march 2015 rajasekar
Isg chennai march 2015 rajasekar
 

Recently uploaded

Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 

Recently uploaded (20)

Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 

Live Donor Renal Transplantation in Sri Lanka

  • 1. Gunawansa N, Cassim MRN, Wijeyaratne SM. LIVE DONOR RENAL TRANSPLANTATION IN SRILANKA: FACTORS AFFECTING OVERALL OUTCOME
  • 2. Kidney transplantation is the most effective therapy for ESRD Ojo, J Am Soc Neph, 2001;12:589 LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 1
  • 3. Introduction • Medium and long-term patient / graft survival statistics after Live Donor Renal Transplantation (LDRT) in Sri Lanka is largely unknown • The overall outcome of LDRT depends on numerous patient, donor and graft related variables • Early identification of above predictors will help in optimizing overall graft and patient outcomes LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 2
  • 4. Methodology • Prospective computerized database • July 2006 – November 2011 • University Vascular and Transplant Unit, Colombo. • Inclusion – All consecutive LDRT • Exclusion – re-transplants, cadaveric LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 3
  • 5. Methodology contd. • All transplants performed as simultaneous donor and recipient operations • relatively constant cold ischaemia time of <2 hours • Standardized immunosuppression regime (MMF, prednisolone, cyclosporin/tacrolimus) • Single dose monoclonal Ab induction for those with a HL A mismatch >50% Graft failure = need for maintenance dialysis, re-transplantation or death due to graft non-function within 1 yr of transplantation* * Weiss-Salz et al. Clin Transplant 2004: 18: 571–575 LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 4
  • 6. Factors Determining Overall Outcome • Type of donor (cadaveric vs. living) • HLA Matching (related, unrelated) • Sensitization • Duration of pre-Tx dialysis • Recipient Age • Donor Age • Cold ischaemia time, warm ischaemia time • Acute rejection, chronic rejection • Primary renal pathology • CMV status LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 5
  • 7. Variables analyzed • Type of donor (cadaveric vs. living) • HLA Matching and sensitization • Duration of pre-Tx dialysis • Recipient Age • Donor Age • Cold ischemia time • Acute rejection, chronic rejection • Primary renal pathology • CMV status • Multivariate log regression LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 6
  • 8. Results • 415 consecutive LDRT • Complete follow-up data available – 397 (95%) • Mean follow-up – 36 (3-66) months. • Mean recipient age – 42 (17-72) years • Mean donor age – 39 (20-60) years LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 7
  • 9. 18 Lost to follow up 397 (95%) complete follow up data 32 (8%) Graft failures 365 (92%) Graft survival 24 PGF 8 SGF 337 (85%) overall patient survival 5 re-transplanted 19 dead 5 re-transplanted or 3 on waiting list 415 LDRT LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 8
  • 10. Results contd. • Graft survival - 365/397 (92%) • Graft Failures (GF); 32 (8%) – 24 primary GF – 05 successfully re-transplanted, 19 dead – 08 secondary GF (Mean graft survival – 10 months) – 05 re-transplanted, 03 activated on waiting list • Overall patient survival – 337/397 (85%) LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 9
  • 11. Causes of death • Sepsis – 48 (80%) • myocardial ischaemia – 4 (7%) • stroke – 4 (7%) • PE – 2 (3%) • Unknown – 2 (3%) Sepsis MI Stroke PE Other LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 10
  • 12. Kaplan- Meir Curve – Graft survival LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 11
  • 13. Predictors of GF Variable Univariate analysis P Multivariate analysis OR (95%CI) P Recipient age: >50y/<50y 0.63 0.06-5.13 0.627 Donor age: >40y/<40y 0.85 0.12-4.22 0.71 CMV infection: Y/N 0.11 0.86-15.07 0.09 HLA mismatch: >50%/<50% 0.04 1.74-6.64 0.07 Pre-Tx dialysis: <12 months/<12 months 0.03 1.17-13.54 0.06 Biopsy proven ac. Rejection: Y/N 0.01 1.35-10.23 0.014 LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 12
  • 14. Conclusions • Our mid-term graft / patient survival figures match favorably with comparable settings elsewhere • Pre-Tx dialysis for >1 year, HLA mismatch of >50% showed a positive correlation to outcome although not statistically significant • Acute rejection within the first month was an independent predictors of poor outcome • Care of primary GF is suboptimal - restricted access to HD, advanced immunosuppressant regimes and the lack of a cadaveric transplant program until now LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 13
  • 15. Recommendations • Earlier referral for transplant • Better HLA match wherever possible • Increasing the donor pool (regular deceased donor program) • A better balance of saving the graft versus saving the patient LIVE DONOR RENAL TRANSPLANTATION IN SRI LANKA: FACTORS AFFECTING OVERALL OUTCOME 14